These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27055469)

  • 61. Phoenix dactylifera, mentha piperita and montanide™ ISA-201 as immunological adjuvants in a chicken model.
    Osman KM; Kamal OE; Deif HN; Ahmed MM
    Acta Trop; 2020 Feb; 202():105281. PubMed ID: 31759920
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in pigs.
    Hilgers LA; Platenburg PL; Luitjens A; Groenveld B; Dazelle T; Weststrate MW
    Vaccine; 1994 May; 12(7):661-5. PubMed ID: 8085386
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken.
    Wang Y; Shan C; Ming S; Liu Y; Du Y; Jiang G
    Res Vet Sci; 2009 Jun; 86(3):399-405. PubMed ID: 18977008
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control.
    Brewer KD; Weir GM; Dude I; Davis C; Parsons C; Penwell A; Rajagopalan R; Sammatur L; Bowen CV; Stanford MM
    J Biomed Sci; 2018 Jan; 25(1):7. PubMed ID: 29374458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
    Wada H; Isobe M; Kakimi K; Mizote Y; Eikawa S; Sato E; Takigawa N; Kiura K; Tsuji K; Iwatsuki K; Yamasaki M; Miyata H; Matsushita H; Udono H; Seto Y; Yamada K; Nishikawa H; Pan L; Venhaus R; Oka M; Doki Y; Nakayama E
    J Immunother; 2014; 37(2):84-92. PubMed ID: 24509171
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
    Baldwin SL; Shaverdian N; Goto Y; Duthie MS; Raman VS; Evers T; Mompoint F; Vedvick TS; Bertholet S; Coler RN; Reed SG
    Vaccine; 2009 Oct; 27(43):5956-63. PubMed ID: 19679214
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant.
    Huang MH; Huang CY; Lien SP; Siao SY; Chou AH; Chen HW; Liu SJ; Leng CH; Chong P
    Pharm Res; 2009 Aug; 26(8):1856-62. PubMed ID: 19415466
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice.
    Silva LA; Souza MF; Carvalho TP; Santana CH; Guedes AC; Oliveira JBS; de Lima PA; Nogueira PRA; de Mello Brandão H; da Paixão TA; Santos RL
    PLoS One; 2024; 19(4):e0298117. PubMed ID: 38573916
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Manufacture of Oil-in-Water Emulsion Adjuvants.
    Haensler J
    Methods Mol Biol; 2017; 1494():165-180. PubMed ID: 27718193
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure.
    Singh M; Hioe C; Qiu H; Li XM; Wang CY; Koff W; Zamb T; Nixon DF
    Vaccine; 1997 Nov; 15(16):1773-8. PubMed ID: 9364682
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant.
    Hilgers LA; Lejeune G; Nicolas I; Fochesato M; Boon B
    Vaccine; 1999 Jan; 17(3):219-28. PubMed ID: 9987157
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review.
    van Doorn E; Liu H; Huckriede A; Hak E
    Hum Vaccin Immunother; 2016; 12(1):159-69. PubMed ID: 26378866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animals.
    Hilgers LA; Platenburg PL; Luitjens A; Groenveld B; Dazelle T; Ferrari-Laloux M; Weststrate MW
    Vaccine; 1994 May; 12(7):653-60. PubMed ID: 8085385
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.
    Lawrence GW; Saul A; Giddy AJ; Kemp R; Pye D
    Vaccine; 1997 Feb; 15(2):176-8. PubMed ID: 9066035
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The use of oil adjuvants in therapeutic vaccines.
    Aucouturier J; Ascarateil S; Dupuis L
    Vaccine; 2006 Apr; 24 Suppl 2():S2-44-5. PubMed ID: 16823921
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stable Nanoemulsions for the Delivery of Small Molecule Immune Potentiators.
    Lodaya RN; Brito LA; Wu TYH; Miller AT; Otten GR; Singh M; O'Hagan DT
    J Pharm Sci; 2018 Sep; 107(9):2310-2314. PubMed ID: 29883663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type.
    Wu N; Chen Q; Zou Y; Miao C; Ma G; Wu J
    Carbohydr Polym; 2023 Jun; 309():120673. PubMed ID: 36906359
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determination of Mycoplasma hyopneumoniae-Specific IgG, IgG1, and IgG2a Titers in BALB/c Mice Induced by Mineral Oil-Based Oil-in-Water Emulsion Adjuvants Prepared Using a Self-Emulsifying Drug Delivery System.
    Bastola R; Seo JE; Noh G; Keum T; Kim JH; Shin JI; Lee S; Lee S
    AAPS PharmSciTech; 2019 Jan; 20(1):31. PubMed ID: 30603786
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Emulsion Adjuvants for Use in Veterinary Vaccines.
    Madera R; Burakova Y; Shi J
    Methods Mol Biol; 2022; 2412():247-253. PubMed ID: 34918248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.